SEC Filings | Enanta Pharmaceuticals, Inc.

SEC Filings

Filing date	Form	Description	Filing Group	View
Dec 05, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001062993-23-021987.pdf 0001062993-23-021987.rtf 0001062993-23-021987.xls
Nov 27, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-012856.pdf 0000000000-23-012856.rtf
Nov 22, 2023	POSASR	POSASR	Other	View HTML 0001193125-23-282244.pdf 0001193125-23-282244.rtf
Nov 22, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	View HTML 0000950170-23-065884.pdf 0000950170-23-065884.rtf 0000950170-23-065884.xls EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
Nov 22, 2023	S-3	Simplified registration form	Registration Statements	View HTML 0001193125-23-282292.pdf 0001193125-23-282292.rtf 0001193125-23-282292.xls
Nov 22, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001062993-23-021379.pdf 0001062993-23-021379.rtf 0001062993-23-021379.xls
Nov 22, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001062993-23-021380.pdf 0001062993-23-021380.rtf 0001062993-23-021380.xls
Nov 22, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001062993-23-021382.pdf 0001062993-23-021382.rtf 0001062993-23-021382.xls
Nov 22, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001062993-23-021381.pdf 0001062993-23-021381.rtf 0001062993-23-021381.xls
Nov 22, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001062993-23-021383.pdf 0001062993-23-021383.rtf 0001062993-23-021383.xls

Data provided by Kaleidoscope.

Print Page Print Page
Email Alerts Email Alerts
RSS Feeds RSS Feeds
Contact IR Contact IR